Drugs / Xylazine
last change Feb 2024 re-read 2 minutes ago

Xylazine

Small molecule

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT06185426 Background Jan 2021 → Jun 2023 facial nerve disorder, nervous system injury Recep Tayyip Erdogan University Unknown No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Xylazine Xylazine HCl (Alfazyne ®, Alfasan International B.V. Woerden, Hollanda) at a dose of 10 mg/kg (intraperitoneal).” NCT06185426
Known as Alfazyne “Xylazine HCl (Alfazyne ®, Alfasan International B.V. Woerden, Hollanda) at a dose of 10 mg/kg (intraperitoneal).” NCT06185426
Known as BAY VA 1470 ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Known as Chanazine ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Known as NSC-758142 ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Known as Xilazina ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Known as Xylazin hydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Known as Xylazine component of tranq ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Known as Xylazine HCl Xylazine HCl (Alfazyne ®, Alfasan International B.V. Woerden, Hollanda) at a dose of 10 mg/kg (intraperitoneal).” NCT06185426
Known as XYLAZINE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL297362
Modality Small molecule CHEMBL297362